Alan H. Lau

1.2k total citations
56 papers, 895 citations indexed

About

Alan H. Lau is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Alan H. Lau has authored 56 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 10 papers in Pediatrics, Perinatology and Child Health and 8 papers in Surgery. Recurrent topics in Alan H. Lau's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Parathyroid Disorders and Treatments (5 papers). Alan H. Lau is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Parathyroid Disorders and Treatments (5 papers). Alan H. Lau collaborates with scholars based in United States, Belgium and Japan. Alan H. Lau's co-authors include Nancy P. Lam, Larry H. Danziger, Stephen C. Piscitelli, Jeffrey R. Koup, Barbara Brodsky, John T. Daugirdas, Kari L. Franson, José A.L. Arruda, James H. Fischer and Richard L. Slaughter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Alan H. Lau

52 papers receiving 840 citations

Peers

Alan H. Lau
Curtis A. Johnson United States
B. Peter Sawaya United States
Richard S. Muther United States
Donald F. Brophy United States
Steven E. Aks United States
Alan H. Lau
Citations per year, relative to Alan H. Lau Alan H. Lau (= 1×) peers Steven Pauwels

Countries citing papers authored by Alan H. Lau

Since Specialization
Citations

This map shows the geographic impact of Alan H. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan H. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan H. Lau more than expected).

Fields of papers citing papers by Alan H. Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan H. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan H. Lau. The network helps show where Alan H. Lau may publish in the future.

Co-authorship network of co-authors of Alan H. Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Alan H. Lau. A scholar is included among the top collaborators of Alan H. Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan H. Lau. Alan H. Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dai, Yuanyuan, et al.. (2020). Oncology clinical pharmacy services in Chinese hospitals. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 988–996. 1 indexed citations
3.
Liao, Yun, Chun-Lai Ma, Alan H. Lau, & Mingkang Zhong. (2020). Role of pharmacists during the COVID ‐19 pandemic in China‐Shanghai experiences. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 997–1002. 25 indexed citations
4.
Nathisuwan, Surakit, Sutthiporn Pattharachayakul, Suphat Subongkot, et al.. (2020). U.S.‐Thai Consortium for the development of pharmacy education in Thailand: History, progress, and impact. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 935–946. 7 indexed citations
5.
Shapiro, Nancy L., Hsiang‐Wen Lin, & Alan H. Lau. (2020). Creation and delivery of a clinical pharmacy practice and education program for international participants in the United States. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 913–919.
6.
Azzopardi, Lilian M., et al.. (2019). Student Perspectives on a Collaborative International Doctorate of Pharmacy Program. SHILAP Revista de lepidopterología. 7(3). 85–85. 4 indexed citations
7.
Malespin, Miguel, et al.. (2014). Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese American Children. Journal of Clinical Gastroenterology. 49(4). 345–349. 30 indexed citations
8.
Kuga, Keisuke, Dong Xu, Morio Ohtsuka, et al.. (2011). Comparison of Daily Anti-Hypertensive Effects of Amlodipine and Nifedipine Coat-Core Using Ambulatory Blood Pressure Monitoring - Utility of“Hypobaric Curve”and“Hypobaric Area”. Clinical and Experimental Hypertension. 33(4). 231–239. 7 indexed citations
9.
Mason, Darius, et al.. (2010). Phosphate‐binding efficacy of crushed vs. chewed lanthanum carbonate in hemodialysis patients. Hemodialysis International. 15(1). 95–99. 7 indexed citations
10.
Mason, Darius, et al.. (2010). Efficacy of chewed vs. crushed lanthanum on phosphorus binding in healthy volunteers. Clinical Nephrology. 73(5). 370–373. 4 indexed citations
11.
Fischer, James H., et al.. (2007). Effects of Lanthanum Carbonate on the Absorption and Oral Bioavailability of Ciprofloxacin. Clinical Journal of the American Society of Nephrology. 2(6). 1235–1240. 33 indexed citations
12.
Lau, Alan H.. (1999). Apoptosis induced by cisplatin nephrotoxic injury. Kidney International. 56(4). 1295–1298. 157 indexed citations
13.
Lau, Alan H., et al.. (1997). Pharmacokinetics and Safety of Tiagabine in Subjects with Various Degrees of Hepatic Function. Epilepsia. 38(4). 445–451. 47 indexed citations
14.
Lau, Alan H., et al.. (1995). Elimination of Flucytosine by Continuous Hemofiltration. American Journal of Nephrology. 15(4). 327–331. 10 indexed citations
15.
Lau, Alan H., et al.. (1995). Estimating equilibrated Kt/V from an intradialytic sample: Effects of access and cardiopulmonary recirculations. Kidney International. 48(3). 832–837. 22 indexed citations
16.
Lau, Alan H., et al.. (1994). Effect of Continuous Hemofiltration on Phenytoin Elimination. Therapeutic Drug Monitoring. 16(1). 53–57. 11 indexed citations
17.
Lau, Alan H., et al.. (1993). Pharmacy Practice and Education in the People's Republic of China. Annals of Pharmacotherapy. 27(10). 1278–1282. 5 indexed citations
18.
Lau, Alan H., et al.. (1992). Clinical Pharmacokinetics of Metronidazole and Other Nitroimidazole Anti-Infectives. Clinical Pharmacokinetics. 23(5). 328–364. 154 indexed citations
19.
Anders, Robert J., Alan H. Lau, Roohollah Sharifi, & Mary Lee. (1987). Comparison of EMIT Versus Bioassay to Evaluate Inactivation of Tobramycin by Piperacillin. Therapeutic Drug Monitoring. 9(4). 472–477. 4 indexed citations
20.
Koup, Jeffrey R., Alan H. Lau, Barbara Brodsky, & Richard L. Slaughter. (1979). Relationship Between Serum and Saliva Chloramphenicol Concentrations. Antimicrobial Agents and Chemotherapy. 15(5). 658–661. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026